Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annals of Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000658-199812000-00007PMID 9860475PMCID PMC1191594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans.

  1998cited by this paper
• Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ

  1998cited by this paper
• Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

  1998cited by this paper
• Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

  1998cited by this paper
• Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma.

  1998cited by this paper
• Resection of colorectal liver metastases

  1997cited by this paper
• Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.

  1997cited by this paper
• Determination of melphalan and hydrolysis products in body fluids by GC-MS

  1997cited by this paper
• Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

  1996cited by this paper
• Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.

  1996cited by this paper
• Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique

  1996cited by this paper
• Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

  1996cited by this paper
• Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

  1996cited by this paper
• VWF release and platelet aggregation in human melanoma after perfusion with TNFα

  1995cited by this paper
• Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha).

  1994cited by this paper
• Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy.

  1994cited by this paper
• Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study

  1994cited by this paper
• Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)

  1994cited by this paper
• Pelvic stopflow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer

  1994cited by this paper
• A percutaneous aortic stop-flow infusion technique for regional cytotoxic therapy of the abdomen and pelvis

  1994cited by this paper
• Use of tumor necrosis factor in isolated hepatic perfusion.

  1994cited by this paper
• Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion.

  1993cited by this paper
• Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.

  1993cited by this paper
• Low‐dose tumour necrosis factor α and melphalan in hyperthermic isolated limb perfusion

  1993cited by this paper
• Dual role of tumor necrosis factor-alpha in angiogenesis.

  1992cited by this paper
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

  1992cited by this paper
• Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

  1991cited by this paper
• Evaluation of measurement of human TNF in plasma by ELISA.

  1991cited by this paper
• Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.

  1991cited by this paper
• Chromatographic analysis of anticancer drugs.

  1990cited by this paper
• A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.

  1990cited by this paper
• Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

  1989cited by this paper
• Resection of hepatic metastases from colorectal cancer. Biologic perspective.

  1989cited by this paper
• Regional treatment of hepatic metastases and hepatocellular carcinoma.

  1989cited by this paper
• Superiority of selective bolus infusion and simultaneous rapid removal of anticancer agents by charcoal hemoperfusion in cancer treatment.

  1988cited by this paper
• In pursuit of evidence based integrated care

  1987cited by this paper
• Phase I study of recombinant tumor necrosis factor in cancer patients.

  1987cited by this paper
• A successful technique of in vivo isolated liver perfusion in pigs.

  1986cited by this paper
• Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

  1986cited by this paper
• Early recognition of hepatocellular carcinoma

  1986cited by this paper
• Pharmacologic rationale for regional drug delivery.

  1984cited by this paper
• The natural history of hepatocellular carcinoma. A study of 100 untreated cases

  1984cited by this paper
• A technique for isolation perfusion of the canine liver with survival.

  1983cited by this paper
• [Isolated liver perfusion with 5-fluorouracil (5-FU) in the human].

  1982cited by this paper
• Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

  1981cited by this paper
• Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention.

  1981cited by this paper

• Immediate results of treatment of patients with metastatic uveal melanoma using isolated liver chemoperfusion. The first domestic experience

  2021cites this paper
• Percutaneous Isolated Hepatic Perfusion for Chemotherapy

  2015cites this paper
• Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility

  2015cites this paper
• Isolated hepatic perfusion: principles and results.

  2014cites this paper
• Foie isolé perfusé : principes et résultats ☆

  2014cites this paper
• Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion

  2014cites this paper
• Liselot BW.indd

  2011cites this paper
• Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

  2010cites this paper
• Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model

  2010cites this paper
• Regional chemotherapy for carcinoma of the lung.

  2008cites this paper
• Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?

  2008cites this paper
• Laboratory models of regional chemotherapy

  2008cites this paper
• Isolated Hypoxic Hepatic Perfusion with Retrograde Outflow in Patients with Irresectable Liver Metastases; A New Simplified Technique in Isolated Hepatic Perfusion

  2008cites this paper
• Isolated Limb and Organ Perfusion Laboratory Models

  2007cites this paper
• Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases

  2007cites this paper
• Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors

  2006cites this paper
• Endovascular isolated hepatic perfusion under pneumoperitoneum.

  2006cites this paper
• Histamine’s vasoactive properties improving response rates in solid tumor treatment

  2006cites this paper
• Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.

  2005cites this paper
• Liposomal cytokines in the treatment of infectious diseases and cancer.

  2005cites this paper
• Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial.

  2005cites this paper
• Liposomal cytokines in the treatment of infectious diseases and cancer.

  2005cites this paper
• Impaired neutralising antibody formation and high transduction efficacy after isolated hepatic perfusion with adenoviral vectors

  2004cites this paper
• Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases.

  2004cites this paper
• Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver

  2004cites this paper
• Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs.

  2004cites this paper
• Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.

  2004cites this paper
• Balloon catheter hypoxic abdominal perfusion with Mitomycin C and Melphalan for locally advanced pancreatic cancer: a phase I-II trial.

  2004cites this paper
• Isolated Liver and Limb Perfusion in Preclinical and Clinical Studies: gene therapy and biochemotherapeutic strategies

  2004cites this paper
• DNA adduct formation and physiological effects from crude oil distillate and its derived base oil in isolated, perfused rat liver

  2004cites this paper
• Isolated hepatic perfusion: experimental evidence and clinical utility.

  2004cites this paper
• Isolated Hypoxic Hepatic Perfusion With Orthograde or Retrograde Flow in Patients With Irresectable Liver Metastases Using Percutaneous Balloon Catheter Techniques: A Phase I and II Study

  2004cites this paper
• True versus Mild Hyperthermia during Isolated Hepatic Perfusion: Effects on Melphalan Pharmacokinetics and Liver Function

  2004cites this paper
• Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study.

  2003cites this paper
• An experimental minimally invasive perfusion technique for the treatment of liver metastases.

  2003cites this paper
• Tumor Necrosis Factor in Isolated Hepatic Perfusion: credits, debits and future directions

  2003cites this paper
• Solid Tumor Therapy: Manipulation of the Vasculature with TNF

  2003cites this paper
• Reduced Liver Uptake of Arterially Infused Melphalan during Retrograde Rat Liver Perfusion with Unaffected Liver Tumor Uptake

  2002cites this paper
• Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience.

  2002cites this paper
• Isolated liver perfusion for non-resectable liver tumours: a review.

  2002cites this paper
• Intratumoral Administration of Low Doses of an Adenovirus Vector Encoding Tumor Necrosis Factor α Together with Naive Dendritic Cells Elicits Significant Suppression of Tumor Growth without Toxicity

  2001cites this paper
• TNF is here to stay--revisited.

  2001cites this paper
• Chimiothérapie par perfusion isolée du foie avec clampage cave endovasculaire : expériences préliminaires chez le porc

  2000cites this paper
• A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.

  2000cites this paper
• Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats.

  2000cites this paper
• [Chemotherapy by isolated liver perfusion with endovascular occlusion catheter: preliminary experience in pigs].

  2000cites this paper
• Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.

  2000cites this paper
• Tumor Necrosis Factor-&agr; Augments Tumor Effects in Isolated Hepatic Perfusion With Melphalan in a Rat Sarcoma Model

  2000cites this paper
• Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver

  2000cites this paper
• Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure.

  2000cites this paper
• Experimentelle Therapie von Lebermetastasen

  1999cites this paper